Principles of Clinical Cannabinology: A Comprehensive Guide to Medical Cannabis in Europe: SECOND EDITION

Principles of Clinical Cannabinology: A Comprehensive Guide to Medical Cannabis in Europe SECOND EDITION The essential reference for prescribing medical cannabis safely and effectively in Europe. Co-authored by Cannabiscientia SA and Prohibition Partners In recent years, many European countries have legalized or regulated Medical Cannabis, yet healthcare professionals and patients still face a significant knowledge gap regarding its therapeutic use, pharmacology, and legal frameworks. Principles of Clinical Cannabinology – Second Edition bridges that gap — offering a science-based, clinically oriented, and regulation-aware overview of cannabinoid medicine across Europe. What this book offers 600+ pages and 800+ scientific references 30+ pathologies reviewed through scientific and clinical evidence Ebook and paperback editions available Legislative and product insights curated by Prohibition Partners Analysts Country-by-country overview for EU nations, the UK, and Switzerland, detailing: Prescription pathways Authorized prescribers Insurance and reimbursement protocols Available products and pharmacy retail prices A comprehensive structure for medical professionals Developed by an international team of clinicians, researchers, and educators, this handbook serves as a practical guide and academic reference for physicians, pharmacists, nurses, and allied health professionals seeking to expand their expertise in cannabinoid medicine. Part I – The Endocannabinoid System (ECS) Explores the body’s intrinsic network for maintaining homeostasis, the role of endocannabinoids, and how cannabis derivatives modulate these pathways to produce therapeutic effects. Part II – Pharmacology of Cannabis Sativa L. Analyzes THC, CBD, minor cannabinoids, terpenes, and flavonoids, linking biochemical function to clinical relevance. Part III – Clinical Evidence and Case Studies Summarizes the latest global research and includes practical insights from experienced prescribers worldwide, supporting evidence-based treatment and patient care. Part IV – European Legislation and Market Overview Covers 20+ countries, comparing public vs. private systems, regulatory frameworks, and evolving access models. Updated regularly to reflect policy and market shifts. Pathologies Covered Include Neurological & Neurodegenerative: Parkinson’s, Alzheimer’s, Epilepsy, Multiple Sclerosis Musculoskeletal: Orthopedic pain, Muscular dystrophy, Low back pain ️ Cardiovascular: Hypertension, Ischemia, Glaucoma Metabolic & Palliative: Diabetes, Obesity, Glioblastoma, Spinal Cord Injury Neuropsychiatric: PTSD, Autism, Migraine, Fibromyalgia, Sleep disorders Gastrointestinal: IBS, IBD, Gastroparesis, Gastritis Dermatological: Psoriasis, Eczema ️ Drug Interactions & Antibiotic Resistance A living textbook Each edition of Principles of Clinical Cannabinology evolves with: New countries and regulations Updated case studies and research Insights on emerging formulations and products By integrating clinical experience, scientific rigor, and regulatory insight, this book empowers healthcare professionals to navigate the complex intersection of medicine, science, and policy, offering practical guidance for safe and effective cannabinoid therapy. Ad Maiora.